Free Trial
OTCMKTS:ALIOF

ALIOF (ALIOF) Stock Price, News & Analysis

$278.50
0.00 (0.00%)
(As of 09/27/2022)
Today's Range
$278.50
$278.50
50-Day Range
$278.50
$278.50
52-Week Range
$138.01
$286.30
Volume
N/A
Average Volume
924 shs
Market Capitalization
$29.89 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ALIOF stock logo

About ALIOF Stock (OTCMKTS:ALIOF)

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

ALIOF Stock Price History

ALIOF Stock News Headlines

See More Headlines
Receive ALIOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/16/2015
Today
6/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:ALIOF
CIK
N/A
Employees
N/A
Year Founded
1997

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$29.89 billion
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Should I Buy ALIOF Stock? ALIOF Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in ALIOF:

  • ALIOF stock price has been steadily increasing, indicating potential growth.
  • Recent positive earnings reports show a strong financial performance, which may attract investors.
  • ALIOF has a low debt-to-equity ratio, signifying financial stability and lower risk.
  • Insiders own a significant percentage of ALIOF stock, indicating confidence in the company's future.
  • ALIOF has a diversified product portfolio, reducing dependency on a single market segment.

Cons

Investors should be bearish about investing in ALIOF for these reasons:

  • ALIOF's stock price may be volatile, leading to potential investment risks.
  • Market competition could impact ALIOF's market share and profitability.
  • Global economic uncertainties may affect ALIOF's international operations and revenue.
  • Changes in government regulations or trade policies could impact ALIOF's business operations.
  • ALIOF's dividend payout ratio may be lower compared to industry peers, affecting income for dividend investors.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 3, 2024. Please send any questions or comments about these ALIOF pros and cons to contact@marketbeat.com.

ALIOF Stock Analysis - Frequently Asked Questions

How have ALIOF shares performed in 2024?

ALIOF's stock was trading at $278.50 at the start of the year. Since then, ALIOF stock has increased by 0.0% and is now trading at $278.50.
View the best growth stocks for 2024 here
.

How were ALIOF's earnings last quarter?

ALIOF (OTCMKTS:ALIOF) released its quarterly earnings results on Monday, February, 16th. The company reported $0.87 EPS for the quarter, missing analysts' consensus estimates of $1.09 by $0.22. The company earned $501.50 million during the quarter, compared to the consensus estimate of $546.30 million.

How do I buy shares of ALIOF?

Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ALIOF) was last updated on 6/4/2024 by MarketBeat.com Staff

From Our Partners